While hospitalizations and deaths from COVID-19 are markedly lower than previous peaks, there are still hundreds of people dying from COVID-19 each day. The evidence-based actions below can help us save more patients from the impacts of the COVID-19.
Download the Surgeon General’s letter
Share this page
“I want to express my deep gratitude for everything you have done for your patients and communities during the COVID-19 pandemic. I know that you have made numerous sacrifices and worked countless hours.”
—Dr. Vivek H. Murthy
U.S. Surgeon General
Additional Resources
Talking with Patients about COVID-19 Vaccination
Centers for Disease Control and Prevention
This is a 4-step CDC guide on how to talk effectively with patients about COVID-19 vaccines.
Share
- Share Talking with Patients about COVID-19 Vaccination to Facebook
- Share Talking with Patients about COVID-19 Vaccination to Twitter
- Share Talking with Patients about COVID-19 Vaccination on LinkedIn
- Share Talking with Patients about COVID-19 Vaccination in an email
Clinical Care Quick Reference for COVID-19
Centers for Disease Control and Prevention
This quick reference highlights key COVID-19 Clinical Care information for healthcare professionals and provides selected links to full guidance and research for easier CDC web navigation.
Share
- Share Clinical Care Quick Reference for COVID-19 to Facebook
- Share Clinical Care Quick Reference for COVID-19 to Twitter
- Share Clinical Care Quick Reference for COVID-19 on LinkedIn
- Share Clinical Care Quick Reference for COVID-19 in an email
COVID-19 Therapeutics Decision Aid
Administration for Strategic Preparedness and Response
This is a anti-viral treatment decision-aid for ages 12+ years, created by ASPR (Administration for Strategic Preparedness and Response).
Share
- Share COVID-19 Therapeutics Decision Aid to Facebook
- Share COVID-19 Therapeutics Decision Aid to Twitter
- Share COVID-19 Therapeutics Decision Aid on LinkedIn
- Share COVID-19 Therapeutics Decision Aid in an email
Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition
JAMA Network
This is a study published in March 2023 by Berkeley about the effect of antivirals.
Share
- Share Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition to Facebook
- Share Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition to Twitter
- Share Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition on LinkedIn
- Share Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition in an email